Hims & Hers Health (HIMS) Cost of Revenue (2020 - 2026)

Hims & Hers Health has disclosed Cost of Revenue across 7 years of filings, most recently posting $272.4 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 25.04% year-over-year to $272.4 million; the TTM figure through Jun 2026 stood at $964.6 million (up 13.16% YoY), while the FY2025 annual figure was $919.3 million, up 35.42% from the prior year.
• Cost of Revenue came in at $272.4 million for Q2 2026 at Hims & Hers Health, up from $222.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $272.4 million in Q2 2026 to a low of $48.1 million in Q1 2022.
• Average Cost of Revenue over 5 years is $156.2 million, with a median of $137.7 million recorded in 2024.
• Year-over-year, Cost of Revenue jumped 116.47% in 2022 and slipped 3.99% in 2026.
• Over 5 years, Cost of Revenue stood at $85.5 million in 2022, then jumped by 47.17% to $125.9 million in 2023, then jumped by 75.61% to $221.1 million in 2024, then grew by 7.67% to $238.0 million in 2025, then gained by 14.43% to $272.4 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $272.4 million in Q2 2026, $222.0 million in Q1 2026, and $238.0 million in Q4 2025.